Title: Hutchinson JH, et al. 5-lipoxygenase-activating protein inhibitors: development of 3--tert-butylsulfanyl-1--(6-methoxy-pyridin-3-yl)-benzyl-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl-2,2-dimethyl-propionic acid (AM103). J Med Chem. 2009 Oct 8;52(19):5803-15.
Title: Lorrain DS, et al. Pharmacological characterization of 3--tert-butylsulfanyl-1--(6-methoxy-pyridin-3-yl)-benzyl-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl-2,2-dimethyl-propionic acid (AM103), a novel selective 5-lipoxygenase-activating protein inhibitor that reduces acute and chronic inflammation. J Pharmacol Exp Ther. 2009 Dec;331(3):1042-50.